EAM Global Investors LLC Buys New Shares in Doximity, Inc. (NASDAQ:DOCS)

EAM Global Investors LLC acquired a new position in Doximity, Inc. (NASDAQ:DOCS - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 99,752 shares of the company's stock, valued at approximately $5,326,000. EAM Global Investors LLC owned about 0.05% of Doximity at the end of the most recent quarter.

A number of other large investors have also modified their holdings of DOCS. FMR LLC lifted its stake in Doximity by 37.6% during the 4th quarter. FMR LLC now owns 9,409,313 shares of the company's stock worth $502,363,000 after acquiring an additional 2,571,580 shares in the last quarter. Arrowstreet Capital Limited Partnership boosted its stake in shares of Doximity by 708.7% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,510,416 shares of the company's stock valued at $80,641,000 after buying an additional 1,323,634 shares in the last quarter. Invesco Ltd. boosted its position in Doximity by 525.1% during the fourth quarter. Invesco Ltd. now owns 1,272,403 shares of the company's stock worth $67,934,000 after purchasing an additional 1,068,849 shares in the last quarter. Franklin Resources Inc. boosted its position in Doximity by 1,178.3% during the fourth quarter. Franklin Resources Inc. now owns 1,062,211 shares of the company's stock worth $56,711,000 after acquiring an additional 979,113 shares during the last quarter. Finally, Lord Abbett & CO. LLC purchased a new position in shares of Doximity in the 3rd quarter worth $29,453,000. Hedge funds and other institutional investors own 87.19% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on DOCS. Bank of America upped their target price on Doximity from $54.00 to $57.00 and gave the company a "neutral" rating in a research report on Monday, January 6th. Leerink Partners upgraded Doximity from a "market perform" rating to an "outperform" rating and lifted their target price for the stock from $60.00 to $90.00 in a report on Friday, February 7th. Raymond James reaffirmed an "outperform" rating and issued a $83.00 price objective (up previously from $65.00) on shares of Doximity in a research note on Friday, February 7th. Canaccord Genuity Group lifted their target price on Doximity from $60.00 to $71.00 and gave the company a "hold" rating in a research note on Friday, February 7th. Finally, Needham & Company LLC raised their target price on Doximity from $65.00 to $82.00 and gave the company a "buy" rating in a report on Friday, February 7th. Eleven equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $65.00.

Doximity Stock Down 4.2 %

NASDAQ:DOCS traded down $2.21 during trading hours on Monday, reaching $51.00. The company had a trading volume of 632,673 shares, compared to its average volume of 1,979,778. The firm has a market cap of $9.52 billion, a price-to-earnings ratio of 51.00, a P/E/G ratio of 4.10 and a beta of 1.41. The business's 50-day simple moving average is $62.97 and its two-hundred day simple moving average is $55.92. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $85.21.

Insider Buying and Selling at Doximity

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the transaction, the director now directly owns 6,360 shares of the company's stock, valued at approximately $366,463.20. This represents a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 37.40% of the company's stock.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.